Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2001

View Archived Issues

Agile Therapeutics to evaluate once-weekly contraceptive patch in phase II trials

Zonagen's lead SPRM shows potential in treatment of endometriosis

Pipeline and program update provided by Texas Biotechnology

N-Acetylcysteine deserves further evaluation in Crohn's disease according to pilot study

CancerVax therapeutic vaccine significantly increases survival in late-stage cancers

Biota acquires NuMAX

Pharmacia's Vestra deemed not approvable by FDA

NitroMed's NO-donating proton pump inhibitors proven superior to lansoprazole in ulcer models

Promising preliminary results reported for AGI-1067 in postangioplasty restenosis

TAK-637, a selective, nonpeptide NK1 antagonist for IBS

Cambridge Antibody Technology reviews product pipeline

ETA antagonist delays disease progression, improves quality of life in late-stage prostate cancer

Company Profile: ALviva

Interim results of two Revimid studies presented at Myeloma Workshop

Vertex ICE inhibitor may have promise in inflammatory and autoimmune skin diseases

Preclinical studies support further testing of noscapine in malignant melanoma

Interferon Sciences licenses novel approach for prevention of tumor recurrence

ATS 2001: AWD-12-281 has beneficial effects on mucus secretion and lung neutrophilia

New research broadens understanding of mechanism of action for SAANDs

Obesity-related gene, methods for diagnosis and treatment of obesity, disclosed in recent patent

Adhesion receptor antagonists reported by Merck as useful in thrombotic disorders

Potential antidepressants in the GSK pipeline

Synthesis and use of azepinoindole PARP inhibitors in neurodegenerative disorders

Antiischemic adenosine agonists designed by Pfizer

Two patents issued for Lilly's new serotonergic piperidine derivatives

GlycoDesign and Leo select antithrombotic drug candidates

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...